Take a deeper dive

News & Events

Nuventra’s Senior Consultants to Speak about the Path to IND at September’s LaunchBio Event

Nuventra Pharma Sciences will present at LaunchBio’s Larger Than Life Science Event on Thursday, September 6, 2018. This monthly event series features networking opportunities, workshops, and panel discussions led by North Carolina’s life science thought leaders. Nuventra’s workshop will focus on navigating the FDA’s Investigational New Drug (IND) program to start clinical trials.

Nuventra’s CEO, Geoff Banks, Ph.D., and Senior Consultants, Todd Shearer, Ph.D. and Mark Bush, Ph.D., will lead the session titled, “The Path to IND: Roadblocks, Milestones, and Success Stories,” as they explore key Clinical Pharmacology IND strategies to use on your company’s path to IND.

The second half of this session will feature a panel discussion with Paul Feldman, Ph.D., Head of Discovery and Translational Medicine at Intarcia Therapeutics, Inc. and Lini Pandite, M.D., Chief Medical Officer at Shattuck Labs. Paul and Lini will share their experience and provide some useful tips on the process.

Nuventra’s consultants will be available to discuss the session and individual questions after the workshop from 6pm to 7pm.

Larger Than Life Science is held the first Thursday of each month. The event is located at the atrium level of the newly renovated Chesterfield Building in downtown Durham from 4pm to 7 pm. Register in advance here.


About Nuventra Pharma Sciences

Nuventra Pharma Sciences was founded in 2008 by Geoffrey Banks, Ph.D. The company offers a wide range of drug development consulting services via senior-level scientists that provide hands-on support to clients. Nuventra’s growth in recent years is based on deep roots in clinical pharmacology and common-sense drug development consulting that delivers real value to clients. Read more at www.nuventra.com

About LaunchBio

LaunchBio is a nonprofit organization that identifies, counsels, and supports high-growth, high-impact life science and biotechnology companies. Its mission is to build an ecosystem of innovation for the benefit of human health and well-being.

LaunchBio’s impact is measured by its success in connecting entrepreneurs with knowledge, capital and talent – including each other – not only within geographic regions, but across the nation’s leading life science hubs. Read more at www.launchbio.org

Back